Skip to Main Content

Paper Details

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes.
Nat Genet
159
2019
Human, Human islet, Human pancreatic islet, T2D, active promoters, associated enhancers, chromatin, diabetes, enhancers, glucose, human, human pancreatic islets, insulin, islet, islet enhancers, linear genome maps, regulatory variants, super-enhancers, target genes, tissue-specific enhancer clusters, type 2 diabetes
Author NameAffiliation
Irene Miguel-Escaladaand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Irene Miguel-EscaladaInstitut d'Investigacions Biomediques August Pi i Sunyer
Irene Miguel-Escalada
Irene Miguel-EscaladaThe Barcelona Institute of Science and Technology
Irene Miguel-Escaladaand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Irene Miguel-EscaladaInstitut d'Investigacions Biomediques August Pi i Sunyer
Irene Miguel-Escalada
Irene Miguel-EscaladaThe Barcelona Institute of Science and Technology
Sílvia Bonàs-Guarchand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Sílvia Bonàs-GuarchInstitut d'Investigacions Biomediques August Pi i Sunyer
Sílvia Bonàs-Guarch
Sílvia Bonàs-GuarchThe Barcelona Institute of Science and Technology
Goutham Atlaand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Goutham AtlaInstitut d'Investigacions Biomediques August Pi i Sunyer
Goutham Atla
Goutham AtlaThe Barcelona Institute of Science and Technology
Claire C Morganand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Claire C MorganThe Barcelona Institute of Science and Technology
Ignasi Moránand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Ignasi Morán
Lorenzo Pasquali
Lorenzo PasqualiGermans Trias i Pujol University Hospital and Research Institute
Lorenzo PasqualiJosep Carreras Leukaemia Research Institute
Emil V R AppelNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Allan LinnebergCenter for Clinical Research and Disease Prevention, Bispebjerg and Frederiksberg Hospital
Allan LinnebergUniversity of Copenhagen
Anette P GjesingNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Daniel R WitteAarhus University
Daniel R Witte
Oluf PedersenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Niels GrarupNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
David Torrents
David TorrentsInstitucio Catalana de Recerca i Estudis Avancats (ICREA)
David Torrents
David TorrentsInstitucio Catalana de Recerca i Estudis Avancats (ICREA)
Josep M Mercader
Josep M MercaderDiabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital
Josep M MercaderBroad Institute of Harvard and MIT
François PattouEuropean Genomic Institute for Diabetes
Leif GroopClinical Research Centre, Lund University
Inga ProkopenkoImperial College London
Inga ProkopenkoUniversity of Surrey
Torben HansenNovo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen
Marc A Marti-RenomBarcelona Institute of Science and Technology
Marc A Marti-RenomInstitucio Catalana de Recerca i Estudis Avancats (ICREA)
Marc A Marti-RenomUniversitat Pompeu Fabra
Marc A Marti-RenomThe Barcelona Institute of Science and Technology
Jorge Ferrerand National Institute for Health Research Imperial Biomedical Research Centre, Imperial College London
Jorge FerrerThe Barcelona Institute of Science and Technology
Jorge Ferrer
  • 1 - 50

Datasets